A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers.

Source:http://linkedlifedata.com/resource/pubmed/id/8304833

Download in:

View as

General Info

PMID
8304833